| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | RVTY Revvity, Inc. | Vohra Tajinder S75 | Please See Remarks | Sell | 5,492 | $116.81 | $641,542.68 | -6.2% | -17.5% | -11.7% | |
| Jan 7, 2025 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 5,000 | $50.00 | $250,000.00 | -23.1% | -18.9% | -19.9% | |
| Jan 7, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 7,689 | $29.66 | $228,066.82 | -0.8% | -40.7% | +26.2% | |
| Jan 6, 2025 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,867 | $29.14 | $229,225.91 | -20.9% | -35.0% | +36.5% | |
| Jan 6, 2025 | CSTL Castle Biosciences Inc | Juvenal Tobin W71 | Chief Commercial Officer | Sell | 2,230 | $30.00 | $66,900.00 | -3.1% | -35.0% | +36.5% | |
| Jan 3, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 144 | $45.59 | $6,565.12 | -0.1% | -20.8% | -31.6% | |
| Jan 3, 2025 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 546 | $45.59 | $24,892.74 | - | -20.8% | -31.6% | |
| Jan 3, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 229 | $45.59 | $10,440.36 | - | -20.8% | -31.6% | |
| Jan 3, 2025 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 160 | $45.59 | $7,294.58 | -0.1% | -20.8% | -31.6% | |
| Jan 2, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $159.50 | $909,125.62 | -0.5% | -10.8% | +42.5% | |
| Jan 2, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 1,430 | $76.04 | $108,736.85 | -1.7% | +6.6% | +66.1% | |
| Jan 2, 2025 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 10,000 | $40.30 | $403,005.64 | -19.3% | -25.5% | +4.8% | |
| Jan 2, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 18,006 | $78.18 | $1,407,686.35 | -4.7% | +6.6% | +66.1% | |
| Dec 26, 2024 | IMDX Insight Molecular Diagnostics Inc. | Arno Andrew | Director | Buy | 12,500 | $2.11 | $26,350.00 | +18.1% | +49.3% | +199.1% | |
| Dec 26, 2024 | IMDX Insight Molecular Diagnostics Inc. | Smith Patrick W66 | 10% Owner | Buy | 90,219 | $2.13 | $192,166.47 | +5.4% | +49.3% | +199.1% | |
| Dec 23, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,428 | $159.60 | $387,511.41 | -0.7% | -5.0% | +45.3% | |
| Dec 23, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 669 | $159.60 | $106,773.49 | -0.3% | -5.0% | +45.3% | |
| Dec 20, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 1,654 | $44.90 | $74,269.56 | -0.2% | -12.3% | -32.2% | |
| Dec 20, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 282 | $44.90 | $12,662.65 | -0.2% | -12.3% | -32.2% | |
| Dec 20, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 316 | $44.90 | $14,189.35 | -0.3% | -12.3% | -32.2% | |
| Dec 19, 2024 | NOTV Inotiv, Inc. | Landman David | Director | Buy | 23,529 | $4.25 | $99,998.25 | +15.3% | -16.7% | -82.6% | |
| Dec 18, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $167.25 | $953,337.28 | -0.5% | -5.7% | +44.8% | |
| Dec 18, 2024 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $34.85 | $4,042.60 | -4.0% | +35.5% | +200.1% | |
| Dec 17, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 9,364 | $28.34 | $265,357.92 | -5.2% | -28.8% | +40.9% | |
| Dec 17, 2024 | PMDI Psychemedics Corp | Powell Anderson Capital Partners LLC | 10% Owner | Buy | 159,700 | $1.91 | $305,439.00 | +6.8% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.